Lidocaine Ointment USP 5% Recalled Due to cGMP Deviations
Teligent Pharma, Inc. is recalling Lidocaine Ointment USP 5% nationwide because the manufacturer is discontinuing its stability study program, which constitutes a deviation from current good manufacturing practice (cGMP). All products within their expiration dates are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a cGMP deviation (manufacturing practice deficiency) rather than a direct safety or efficacy threat. The source text does not report any adverse health events or patient harm, making this a precautionary recall based on regulatory non-compliance.
Plain-English summary
Teligent Pharma, Inc. is recalling Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tubes manufactured for Hi-Tech Pharmacal Co., Inc. The recall applies to Batch 16695 with expiration date 4/30/2024. All products within their expiration dates are included in the recall.
The recall was initiated because the firm is discontinuing its stability study program, which represents a deviation from current good manufacturing practice (cGMP) standards required by the FDA for pharmaceutical manufacturing.
The product was distributed nationwide in the USA and Puerto Rico. Approximately 49,081 tubes are affected. The product is prescription only (Rx Only) and bears NDC 50383-341-35.
Consumers and healthcare providers who have this product should stop using it and consult with their pharmacist or healthcare provider about alternatives. Patients should not stop taking prescribed medication without medical guidance.
The recalled product
- Product
- Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-341-35.
- Manufacturer
- Teligent Pharma, Inc.
- Hazard
- cgmp-deviation
- manufacturing-control
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 16695
- Exp 4/30/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27